233 related articles for article (PubMed ID: 1714518)
1. Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.
Shang F; Huang H; Revesz K; Chen HC; Herz R; Pinter A
J Virol; 1991 Sep; 65(9):4798-804. PubMed ID: 1714518
[TBL] [Abstract][Full Text] [Related]
2. Characterization of murine monoclonal antibodies directed against the submembrane protein p17 of HIV-1.
Niedrig M; Harthus HP; Bröker M; Meloen R; Gelderblom H; Pauli G
Hybridoma; 1993 Aug; 12(4):431-9. PubMed ID: 7503941
[TBL] [Abstract][Full Text] [Related]
3. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera.
Liu X; Ota A; Watanabe M; Ueda S; Saitoh A; Shinagawa H; Nakata A; Kurimura T; Wang X; Zhao Y
Microbiol Immunol; 1995; 39(10):775-85. PubMed ID: 8577268
[TBL] [Abstract][Full Text] [Related]
4. Epitope mapping of monoclonal antibodies against human immunodeficiency virus type 1 structural proteins by using peptides.
Niedrig M; Hinkula J; Weigelt W; L'age-Stehr J; Pauli G; Rosen J; Wahren B
J Virol; 1989 Aug; 63(8):3525-8. PubMed ID: 2473220
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping.
Papsidero LD; Sheu M; Ruscetti FW
J Virol; 1989 Jan; 63(1):267-72. PubMed ID: 2462060
[TBL] [Abstract][Full Text] [Related]
6. Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2.
Niedrig M; Hinkula J; Harthus HP; Bröker M; Hopp L; Pauli G; Wahren B
J Virol; 1991 Aug; 65(8):4529-33. PubMed ID: 1712863
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
Ota A; Tanaka-Taya K; Ueda S
Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
[TBL] [Abstract][Full Text] [Related]
8. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
Madaule P; Gairin JE; Bénichou S; Rossier J
FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777
[TBL] [Abstract][Full Text] [Related]
9. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
10. Characterization of antibodies reacting with HIV gag proteins occasionally found in the serum of non-infected subjects.
Bürgisser P; Frei PC
Clin Exp Immunol; 1991 Aug; 85(2):219-23. PubMed ID: 1713811
[TBL] [Abstract][Full Text] [Related]
11. Immunodominant epitopes of HIV-1 p17 and p24.
Graham S; Follett EA; Wallace L; Desselberger U; Marsden HS
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1781-8. PubMed ID: 1280955
[TBL] [Abstract][Full Text] [Related]
12. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.
Ota A; Liu X; Fujio H; Sakato N; Ueda S
Hybridoma; 1998 Feb; 17(1):73-5. PubMed ID: 9523241
[TBL] [Abstract][Full Text] [Related]
13. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
[TBL] [Abstract][Full Text] [Related]
14. Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides.
Blomberg J; Vincic E; Jönsson C; Medstrand P; Pipkorn R
AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1363-72. PubMed ID: 2127683
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
Mehta SU; Rupprecht KR; Hunt JC; Kramer DE; McRae BJ; Allen RG; Dawson GJ; Devare SG
AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping of a monoclonal antibody which binds HIV-1 Gag and not the Gag-derived proteins.
Sarubbi E; Denaro M
FEBS Lett; 1993 Dec; 335(3):335-7. PubMed ID: 7505237
[TBL] [Abstract][Full Text] [Related]
17. Multiple antigenic epitopes expressed on gag proteins, p26 and p15, of a human immunodeficiency virus (HIV) type 2 as defined with a library of monoclonal antibodies.
Komatsu H; Tozawa H; Kawamura M; Kodama T; Hayami M
AIDS Res Hum Retroviruses; 1990 Jul; 6(7):871-81. PubMed ID: 1697178
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
Kageyama S; Katsumoto T; Taniguchi K; Ismail SI; Shimmen T; Sasao F; Gao M; Owatari S; Wakamiya N; Tsuchie H; Ueda S; Shiraki K; Kurimura T
Acta Virol; 1996 Sep; 40(4):195-200. PubMed ID: 9014009
[TBL] [Abstract][Full Text] [Related]
19. A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE.
Buratti E; Tisminetzky SG; D'Agaro P; Baralle FE
J Virol; 1997 Mar; 71(3):2457-62. PubMed ID: 9032383
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
